NanoCellect Biomedical Inc

NanoCellect is committed to empowering every scientist to make discoveries one cell at a time, with modern and simple technologies for to advance cell based assays that are affordable, compact, and easy-to-use. Our microfluidic flow cytometry platforms enable biomedical scientists to analyze and sort cells required for drug discovery, single cell-omics, cloning, and basic research. The company was founded in late 2009 as a spinout from UCSD and dedicated 6 years developing the foundation of the WOLF’s technology before introducing the WOLF to early adopters in 2016. Initial funding of R&D was graciously provided by multiple NIH SBIR grants and contracts. Additionally, we are backed by Illumina Ventures, FusionX Ventures, Anzu Partners, Agilent Technologies, Vertical Ventures and other private investors.